Jonathan Coakham
Psychiatry · Greenville, NCNPI 1669034872
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 199 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations.
Across 199 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$673
- Johnson & Johnson$542
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$533
- AbbVie$459
- Lundbeck LLC$289
- Alkermes, Inc.$260
- plus $730 from 10 others
What the payments were for
- Food & beverage$3,487100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 30 | $673 |
| Johnson & Johnson | 33 | $542 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 33 | $533 |
| AbbVie | 31 | $459 |
| Lundbeck LLC | 22 | $289 |
| Alkermes, Inc. | 12 | $260 |
| Otsuka America Pharmaceutical, Inc. | 14 | $236 |
| Axsome Therapeutics, Inc. | 7 | $177 |
| Teva Pharmaceuticals USA, Inc. | 6 | $115 |
| E.r. Squibb & Sons, L.L.C. | 3 | $60 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Indivior Inc. | 1 | $16 |
| Tris Pharma Inc | 1 | $16 |
How this compares
$3,487 in reported general payments places this provider in the 85th percentile of 1,108 psychiatry providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 30 | $380 |
| Quetiapine Fumarate | 39 | $293 |
| Prazosin Hcl | 18 | $193 |
| Hydroxyzine Hcl | 24 | $187 |
| Mirtazapine | 19 | $175 |
| Divalproex Sodium | 13 | $155 |
| Lamotrigine | 11 | $144 |
| Zolpidem Tartrate | 16 | $109 |
| Trazodone Hcl | 30 | $107 |
| Sertraline Hcl | 23 | $80 |
| Clonazepam | 16 | $80 |
| Fluoxetine Hcl | 13 | $28 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Greenville
- Kathy MayoGreenville$14K
- Craig ChepkeHuntersville$4.1M
- Mark ReynoldsDurham$3.2M
- James BarkerHickory$2.1M
- Brian FarahWinston Salem$605K
- Krishna TalluriMorrisville$591K
- Ramesh GihwalaGastonia$545K
- Keshavpal ReddyGreensboro$480K
- Robert MilletRaleigh$476K
- Steven SzaboDurham$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.